U.S. Physical Therapy, Inc. (USPH)

NYSE • Healthcare

$88.53

-$0.2 (-0.2%)

Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$88.16

Day Range$85.44 - $88.86

Avg. Volume (3M)170.5K

Market Cap$1.3B

P/E Ratio520.8

52 Week Range

$58.19$93.26

Next EarningsIn 11 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$214M100%

Gross Profitminus cost of goods$41.9M20%

Operating Incomeminus R&D and overhead$21.9M10%

Net Incomeminus taxes and the rest$1.6M1%

In plain terms: out of every $100 in revenue, U.S. Physical Therapy, Inc. keeps $1 as net profit.

Fundamentals & Financials

Revenue (TTM)

$779M

Net Income (TTM)

-$6M

EPS (TTM)

$0.17

ROA (TTM)

-0.48%

Current Ratio

1.27

Dividend Yield

1.34%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+14.1%Q3 2025$0.81

-1.5%Q4 2025$0.66

0.0%Q1 2026$0.67

-16.4%Q2 2026$0.46

-7.9%Q3 2026$0.75

Nov 4

in 11 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Miss -7.9%

U.S. Physical Therapy’s adjusted EPS missed consensus in the second fiscal quarter of 2026, based on preliminary results reported Aug. 5. Revenue fell about 15% to roughly $139.3 million from $164.2 million a year earlier, while gross margin held near 33% and operating margin came in around 14% as operating income reached about $19.5 million. Adjusted EPS of $0.75 missed the $0.81 consensus by about 8% and was down about 7% from $0.81 a year ago. The company generated operating cash flow of about $38.2 million, repurchased about $19.2 million of stock, and paid about $13.9 million in dividends. Consensus for the next period calls for EPS of $0.79.

Next report — what to expect

U.S. Physical Therapy, Inc. (USPH) reports on November 4, 2026. Wall Street expects EPS of $0.76 on revenue of $214.5 million. For trailing context, revenue rose +30.4% year over year last quarter. USPH has beaten EPS in 3 of its 8 most recent quarters, making consistency a key item to watch.

View full earnings history

About U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc. provides rehabilitation and treatment care through outpatient clinics and workplace-focused injury services, making it a healthcare operator in the medical care facilities field. The company trades on the NYSE as USPH and generated $781.0 million of revenue in FY2025.

Name

U.S. Physical Therapy, Inc.

CEO

Christopher J. Reading

Website

www.usph.com

Industry

Healthcare

Year Founded

1990

Employees

6,374

Today's Snapshot

AI-generated

The day ended with USPH slightly lower at 88.53, while its sector was weaker. Volume was about two-thirds of its usual level.

Trading Volume

Below 10d avg (150.6K)

102.9K

vs S&P 500 Today

Moderate Outperformance

+0.29%

Updated: October 23, 2026 at 20:16 UTC

Technical Indicators

6 Buy1 Neutral1 Sell

USPH, trading near $88.53, shows a constructive bias as price sits well above its short, medium and 200-day averages while momentum indicators are generally positive. The MACD and CCI point to bullish internals, although the stochastic and Williams signals suggest near-term overbought readings; ADX around the mid-teens indicates the trend is present but not strong. Volume on OBV is softer, and ATR suggests moderate intraday movement, with the classic pivot just under the current price acting as nearby support. Technical takeaway: Buy.

All signals